All Insights
Showing 37 - 48 of 325
Regulatory and compliance
New NPPS sets out 'value for money' message for UK public procurement
Government wants public bodies to use procurement to drive growth, social and economic value, and commercial capability
Life Sciences and Healthcare
Genetic resources, IP and benefits sharing: what changes are ahead internationally?
The WIPO has set out disclosure rules for patent applications as the UN pushes for sharing digital sequence information
Life Sciences and Healthcare
Streamlined reimbursement law looks to boost medicine access in Poland
What can Poland's pharmaceutical industry expect from further reforms due in the second quarter of this year?
IT and data
What will be the impact of the European Health Data Space Regulation on life sciences companies?
The EHDS is in its final stages, creating a common data space for the first time
Life Sciences and Healthcare
What governance challenges does the UK engineering biology sector face?
The Regulatory Horizons Council's latest report outlines recommendations on ensuring effective governance of engineering biology products
Life Sciences and Healthcare
AI literacy becomes mandatory for life sciences across the EU
The pharma and medtech sectors have a strategic window to implement AI literacy ahead of an August enforcement deadline
Life Sciences and Healthcare
EU General Court's invalidity finding on 3D shape mark highlights med devices' trade mark woes
Ruling that shape was functional is consistent with trade mark law's aim to prevent monopolies on technical solutions
Life Sciences and Healthcare
EU liability directive for defective products set to impact Spain's pharmaceutical sector
Companies need to focus on safety and accessibility compliance before the directive enters national law in late 2026
Life Sciences and Healthcare
Is the engineering biology sector set to be turbocharged in the UK?
A Lords report sets out recommendations for policy the UK must get right and calls for a national sector champion
Life Sciences and Healthcare
'Killer acquisitions' in Europe's pharmaceutical sector: is more regulation needed?
Competition authorities are increasingly focused on the impact of transactions on innovation in the life sciences and healthcare sector.
Life Sciences and Healthcare
Belgium creates a new legal exemption for unauthorised medicines
A novel form of 'named patient use' mechanism is meant to address special pharma needs and drug shortages
Artificial intelligence
How medical technology is navigating the AI Act in Europe
AI is transforming medical products and manufacturing as regulators look to keep pace with developments.
